CHARACTERISTICS OF HYPERTENSION IN PATIENTS WITH ADRENAL TUMORS AT BACH MAI HOSPITAL
Main Article Content
Abstract
Objectives: Characteristics of hypertension and assessment of blood pressure changes after adrenalectomy in patients with adrenal tumors at Bach Mai hospital. Subjects and Methods: The study included 98 patients diagnosed with adrenal tumors at bach mai hospital between August 2024 and April 2025. Results: Hypertension was observed in 87.8% of patients, with 43% requiring ≥3 classes of antihypertensive medications and 26.7% having developed cardiovascular or renal complications. The mean duration of hypertension was 5.96 ± 5.68 years, with the longest duration found in patients with Conn's syndrome. Following surgery, 80.8% of patients reduced the number of antihypertensive drug classes used, and 61.8% achieved hypertension remission. In the Conn’s syndrome group, 49.2% of patients were diagnosed at a late stage; this group had worse renal function, a higher prevalence of cardiovascular comorbidities, required more antihypertensive drug classes, and had a lower post-operative cure rate compared to others (32.1% vs. 77.8%; p = 0.001). Conclusion: Hypertension in patients with adrenal tumors, particularly in Conn's syndrome, is often prolonged and difficult to control. Delayed diagnosis remains common and significantly impacts treatment outcomes. Screening for secondary causes should be emphasized to improve long-term prognosis.
Article Details
Keywords
adrenal tumor, secondary hypertension, endocrine hypertension, hyperaldosteronism.
References
2. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889-1916. doi:10.1210/jc.2015-4061
3. Clemente-Gutiérrez U, Pérez-Soto RH, Hernández-Acevedo JD, et al. Endocrine hypertension secondary to adrenal tumors: clinical course and predictive factors of clinical remission. Langenbecks Arch Surg. 2021;406(6):2027-2035. doi:10.1007/s00423-021-02245-2
4. Giang NTT, Nga VB. Nhận xét đặc điểm lâm sàng, cận lâm sàng và kết quả điều trị u tuyến thượng thận tại Bệnh viện Đại học Y Hà Nội. Vietnam Journal of Diabetes and Endocrinology. 2021;(47):30-35.
5. Ha J, Park JH, Kim KJ, et al. 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism. Endocrinol Metab (Seoul). 2023;38(6):597-618. doi:10.3803/EnM.2023.1789
6. Rossi GP. Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension.
7. Fassnacht M, Tsagarakis S, Terzolo M, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology. 2023;189(1):G1-G42. doi:10.1093/ejendo/lvad066
8. Gupta G, Teo AED, Swee DS, et al. Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors. The Journal of Clinical Endocrinology & Metabolism. Published online December 22, 2023:dgad752. doi:10.1210/clinem/dgad752